← Leaderboards
Leonard B Maggi
Washington University
$473,100
Attributed
$946,200
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $315.4K · FY2015–17$500K$375K$250K$125K$0
'15
'16
'17
Funding mix
By agency
NIH$946,200 · 1
By mechanism
R01$946,200 · 1
Top collaborators
- Michael H Tomasson4 shared
Most similar at Washington University
Same institution · by research overlap
- Jean E Schaffer$33,853,860
- Kathleen B Hall$7,200,714
- Philip J Mason$3,321,325
- Daniel S Ory$14,176,962
- Howard J Edenberg$27,305,449
Others in their field
Top investigators on “Complex”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$385,971,304
- Chanza Baytop · Westat, Inc.$271,217,917
- David R. Weir · University Of Michigan At Ann Arbor$186,776,551
- Barton F Haynes · Duke University$162,931,717
Research focus
ComplexCustomAntibodiesComplementary DnaBaseBiochemicalBiologicalBiological Adaptation To StressB-LymphocytesChromosomes, Human, Pair 4Cell Cycle InhibitionCell DeathCell GrowthCell LineCell NucleolusCellsCell SurvivalCell TransformationChemotherapeutic AgentChemotherapyChemotherapy-Oncologic ProcedureChromosomal TranslocationChromosomesDeep Sequencing
Grant awards (4)
ROLE OF ACA11, AN ORPHAN SMALL NUCLEOLAR RNA IN RESISTANCE TO CANCER CHEMOTHERAPY$315,400
R01 · FY2017 · CA
ROLE OF ACA11, AN ORPHAN SMALL NUCLEOLAR RNA IN RESISTANCE TO CANCER CHEMOTHERAPY$181,640
R01 · FY2016 · CA
ROLE OF ACA11, AN ORPHAN SMALL NUCLEOLAR RNA IN RESISTANCE TO CANCER CHEMOTHERAPY$133,760
R01 · FY2016 · CA
ROLE OF ACA11, AN ORPHAN SMALL NUCLEOLAR RNA IN RESISTANCE TO CANCER CHEMOTHERAPY$315,400
R01 · FY2015 · CA